Global Pharmacogenetic Testing Market - Industry Trends and Forecast to 2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,800	356 Pages	Data Bridge Market Research	October, 2023	DAABD18360503

Best Price Guarantee
Price	from $4,800
Length	356 Pages
Publisher	Data Bridge Market Research
Published Date	October, 2023
SKU	DAABD18360503

Global Pharmacogenetic Testing Market - Industry Trends and Forecast to 2030

The global pharmacogenetic testing market is expected to reach USD 11,442.40 million by 2030 from USD 5,960.00 million in 2022, growing at a CAGR of 8.7% during the forecast period of 2023 to 2030.

Market Segmentation
Global Pharmacogenetic Testing Market, By Type (Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, and Single Gene Tests), Gene Type (CYP2C19, CYP2D6, CYP2C9 AND VKORC1, CYP1A2, HLA-B*1502, HLA-B*5701, CYP2D, OPRM1, ONCOTYPE DX AND MAMMAPRINT, DRD3, D4D4, SLC6A4, HTR2A/C, TMPT, and Others), Drug Type (Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, and Over-the-Counter Medications), Sample (Blood and Saliva), Therapeutic Area (Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology & Hypersensitivity, Dermatology, Gynecology, Oncology, Neurology, and Others), Application (Clinical Practice, Drug Development, and Drug Regulation), End User (Healthcare Providers, Pharmaceutical & Biotechnology Companies, Research Centres and Academic Institutes, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, and Direct-to-Customer Services), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, U.A.E., Israel, Egypt, rest of Middle East and Africa) - Industry Trends and Forecast to 2030.

Overview of Global Pharmacogenetic Testing Market Dynamics

Driver
• Rapid technological advancement and miniaturization
Restrain

• Environment and health concerns
Opportunity

• Rising research and development and innovative technologies

Market Players

Some of the major market players operating in the global pharmacogenetic testing market are:

• Thermo Fisher Scientific
• Illumina, Inc
• QIAGEN
• Sonic Healthcare
• BGI
• PerkinElmer Genomics
• Eurofins Scientific
• 23andMe Holding Co.
• GENEWIZ (A subsidiary of Azenta Life Sciences)
• Luminex Corporation. (A subsidiary of DiaSorin S.p.A.)
• PacBio.
• Assurex Health, Inc. (A subsidiary of Myriad Genetics)
• MD Labs
• OneOme, LLC
• Dynamic DNA Laboratories
• PGXT

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of Global Pharmacogenetic Testing Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Dbmr Market Position Grid; 2.7 Multivariate Modelling; 2.8 Type Lifeline Curve; 2.9 Market End User Coverage Grid; 2.10 Secondary Sources; 2.11 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel Analysis; 4.2 Porter’sfive Forces; 4.3 Industry Insights And Strategic Analysis
5 Market Overview: 5.1 Drivers; 5.1.1 Increasing Adoption Of Personalized Medicine; 5.1.2 Advancements In Genomic Technologies; 5.1.3 Increasing Chronic And Complex Diseases; 5.1.4 Role Of Pharmacogenetic Testing In Drug Discovery And Development; 5.2 Restraints; 5.2.1 Dependency On The Medical And Genomic Expert For Result Interpretation; 5.2.2 Ethical And Privacy Concerns Associated With Pharmacogenetic Testing; 5.3 Opportunities; 5.3.1 Integration With Electronic Health Records (Ehrs); 5.3.2 Artificial Intelligence (Ai) And Machine Learning Integration In Healthcare; 5.4 Challenges; 5.4.1 Challenges In Clinical Implementation Of Pharmacogenetics; 5.4.2 Complexity Associated With Pharmacogenetic Testing Results
6 Global Pharmacogenetic Testing Market, By Type: 6.1 Overview; 6.2 Whole Genome Sequencing; 6.2.1 Next Generation Sequencing (Ngs); 6.2.2 Sanger Sequencing; 6.3 Whole Exome Sequencing; 6.3.1 Next Generation Sequencing (Ngs); 6.3.2 Sanger Sequencing; 6.4 Array-based Tests; 6.4.1 Glass Slide Arrays; 6.4.2 In—situ Synthesized Arrays; 6.4.3 Self Assembled Arrays; 6.5 Single Gene Tests; 6.5.1 Next Generation Sequencing (Ngs); 6.5.2 Sanger Sequencing
7 Global Pharmacogenetic Testing Market, By Gene Type: 7.1 Overview; 7.2 Cyp2c19; 7.3 Cyp2d6; 7.4 Cyp2c9 And Vkorc1; 7.5 Cyp1a2; 7.6 Hla-b*1502; 7.7 Hla-b*5701; 7.8 Cyp2d; 7.9 Oprm1; 7.10 Oncotype Dx* And Mammaprint; 7.11 Drd3; 7.12 D4d4; 7.13 Slc6a4; 7.14 Htr2a/C; 7.15 Tmpt; 7.16 Others
8 Global Pharmacogenetic Testing Market, By Drug Type: 8.1 Overview; 8.2 Prescription Drugs; 8.3 Nutraceuticals; 8.4 Recreational Drugs; 8.5 Herbal Supplements; 8.6 Vitamins; 8.7 Over-the-counter Medications
9 Global Pharmacogenetic Testing Market, By Sample: 9.1 Overview; 9.2 Blood; 9.3 Saliva
10 Global Pharmacogenetic Testing Market, By Therapeutic Area: 10.1 Overview; 10.2 Cardiology; 10.3 Gastroenterology; 10.4 Anesthesiology; 10.5 Genomics; 10.6 Endocrinology; 10.7 Immunology & Hypersensitivity; 10.8 Dermatology; 10.9 Gynecology; 10.10 Oncology; 10.11 Neurology; 10.12 Others
11 Global Pharmacogenetic Testing Market, By Application: 11.1 Overview; 11.2 Clinical Practice; 11.2.1 Side Effects; 11.2.2 Drug Effectiveness; 11.2.3 Dosage; 11.3 Drug Development; 11.3.1 Drug Effectiveness; 11.3.2 Dosage; 11.3.3 Side Effects; 11.4 Drug Regulation; 11.4.1 Side Effects; 11.4.2 Drug Effectiveness; 11.4.3 Dosage
12 Global Pharmacogenetic Testing Market, By End User: 12.1 Overview; 12.2 Healthcare Providers; 12.3 Pharmaceutical & Biotechnology Companies; 12.4 Research Centres And Academic Institutes; 12.5 Others
13 Global Pharmacogenetic Testing Market, By Distribution Channel: 13.1 Overview; 13.2 Hospital Pharmacy; 13.3 Retail Pharmacies; 13.4 Mail-order Pharmacies; 13.5 Direct-to-customer Services
14 Global Pharmacogenetic Testing Market, By Region: 14.1 Overview; 14.2 North America; 14.3 Europe; 14.4 Asia-pacific; 14.5 South America; 14.6 Middle East And Africa
15 Global Pharmacogenetic Testing Market: Company Landscape: 15.1 Company Share Analysis: Global; 15.2 Company Share Analysis: North America; 15.3 Company Share Analysis: Europe; 15.4 Company Share Analysis: Asia-pacific
16 Swot Analysis
17 Company Profile: 17.1 Thermo Fisher Scientific Inc.; 17.1.1 Company Snapshot; 17.1.2 Revenue Analysis; 17.1.3 Company Share Analysis; 17.1.4 Product Portfolio; 17.1.5 Recent Developments; 17.2 Illumina, Inc.; 17.2.1 Company Snapshot; 17.2.2 Revenue Analysis; 17.2.3 Company Share Analysis; 17.2.4 Product Portfolio; 17.2.5 Recent Development; 17.3 Qiagen; 17.3.1 Company Snapshot; 17.3.2 Revenue Analysis; 17.3.3 Company Share Analysis; 17.3.4 Product Portfolio; 17.3.5 Recent Development; 17.4 Sonic Healthcare; 17.4.1 Company Snapshot; 17.4.2 Revenue Analysis; 17.4.3 Company Share Analysis; 17.4.4 Product Portfolio; 17.4.5 Recent Development; 17.5 Bgi; 17.5.1 Company Snapshot; 17.5.2 Company Share Analysis; 17.5.3 Product Portfolio; 17.5.4 Recent Development; 17.6 23andme, Inc; 17.6.1 Company Snapshot; 17.6.2 Revenue Analysis; 17.6.3 Product Portfolio; 17.6.4 Recent Development; 17.7 Dynamic Dna Laboratories; 17.7.1 Company Snapshot; 17.7.2 Product Portfolio; 17.7.3 Recent Development; 17.8 Eurofins Scientific (2022); 17.8.1 Company Snapshot; 17.8.2 Revenue Analysis; 17.8.3 Product Portfolio; 17.8.4 Recent Development; 17.9 Genewix (A Subsidiary Of Azenta Life Science); 17.9.1 Company Snapshot; 17.9.2 Product Portfolio; 17.9.3 Recent Development; 17.10 Luminex Corporation (A Subsidiary Of Diasorin); 17.10.1 Company Snapshot; 17.10.2 Product Portfolio; 17.10.3 Recent Development; 17.11 Md Labs; 17.11.1 Company Snapshot; 17.11.2 Product Portfolio; 17.11.3 Recent Development; 17.12 Myriad Genetics, Inc.; 17.12.1 Company Snapshot; 17.12.2 Revenue Analysis; 17.12.3 Product Portfolio; 17.12.4 Recent Developments; 17.13 Oneome; 17.13.1 Company Snapshot; 17.13.2 Product Portfolio; 17.13.3 Recent Development; 17.14 Pacbio; 17.14.1 Company Snapshot; 17.14.2 Revenue Analysis; 17.14.3 Product Portfolio; 17.14.4 Recent Development; 17.15 Perkinelmer Inc.; 17.15.1 Company Snapshot; 17.15.2 Revenue Analysis; 17.15.3 Product Portfolio; 17.15.4 Recent Development; 17.16 Pgxt; 17.16.1 Company Snapshot; 17.16.2 Product Portfolio; 17.16.3 Recent Development
18 Questionnaire
19 Related Reports
List Of Tables: Table 1 Global Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 2 Global Whole Genome Sequencing In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 3 Global Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 4 Global Whole Exome Sequencing In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 5 Global Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 6 Global Array-based Tests In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 7 Global Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 8 Global Single Gene Tests In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 9 Global Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 10 Global Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million); Table 11 Global Cyp2c19 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 12 Global Cyp2d6 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 13 Global Cyp2c9 And Vkorc1 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 14 Global Cyp1a2 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 15 Global Hla-b*1502 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 16 Global Hla-b*5701 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 17 Global Cyp2d In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 18 Global Oprm1 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 19 Global Oncotype Dx* And Mammaprint In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 20 Global Drd3 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 21 Global D4d4 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 22 Global Slc6a4 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 23 Global Htr2a/C In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 24 Global Tmpt In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 25 Global Others In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 26 Global Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million); Table 27 Global Prescription Drugs In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 28 Global Nutraceuticals In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 29 Global Recreational Drugs In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 30 Global Herbal Supplements In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 31 Global Vitamins In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 32 Global Over-the-counter Medications In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 33 Global Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million); Table 34 Global Blood In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 35 Global Saliva In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 36 Global Pharmacogenetic Testing Market, By Therpaeutic Area, 2021-2030 (Usd Million); Table 37 Global Cardiology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 38 Global Gastroenterology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 39 Global Anesthesiology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 40 Global Genomics In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 41 Global Endocrinology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 42 Global Immunology & Hypersensitivity In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 43 Global Dermatology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 44 Global Gynecology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 45 Global Oncology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 46 Global Neurology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 47 Global Others In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 48 Global Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 49 Global Clinical Practice In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 50 Global Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 51 Global Drug Development In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 52 Global Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 53 Global Drug Regulation In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 54 Global Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 55 Global Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million); Table 56 Global Healthcare Providers In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 57 Global Pharmaceutical & Biotechnology Companies In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 58 Global Research Centres And Academic Institutes In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 59 Global Others In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 60 Global Pharmacogenetic Testing Market, By Distribution Channel, 2020-2030 (Usd Million); Table 61 Global Hospital Pharmacy In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 62 Global Retail Pharmacies In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 63 Global Mail-order Pharmacies In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 64 Global Direct-to-customer Services In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 65 Global Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 66 North America Pharmacogenetic Testing Market, By Country, 2021-2030 (Usd Million); Table 67 North America Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 68 North America Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 69 North America Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 70 North America Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 71 North America Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 72 North America Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million); Table 73 North America Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million); Table 74 North America Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million); Table 75 North America Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million); Table 76 North America Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 77 North America Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 78 North America Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 79 North America Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 80 North America Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million); Table 81 North America Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million); Table 82 U.S. Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 83 U.S. Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 84 U.S. Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 85 U.S. Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 86 U.S. Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 87 U.S. Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million); Table 88 U.S. Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million); Table 89 U.S. Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million); Table 90 U.S. Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million); Table 91 U.S. Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 92 U.S. Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 93 U.S. Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 94 U.S. Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 95 U.S. Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million); Table 96 U.S. Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million); Table 97 Canada Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 98 Canada Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 99 Canada Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 100 Canada Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 101 Canada Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 102 Canada Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million); Table 103 Canada Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million); Table 104 Canada Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million); Table 105 Canada Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million); Table 106 Canada Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 107 Canada Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 108 Canada Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 109 Canada Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 110 Canada Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million); Table 111 Canada Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million); Table 112 Mexico Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 113 Mexico Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 114 Mexico Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 115 Mexico Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 116 Mexico Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 117 Mexico Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million); Table 118 Mexico Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million); Table 119 Mexico Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million); Table 120 Mexico Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million); Table 121 Mexico Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 122 Mexico Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 123 Mexico Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 124 Mexico Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 125 Mexico Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million); Table 126 Mexico Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million); Table 127 Europe Pharmacogenetic Testing Market, By Country, 2021-2030 (Usd Million); Table 128 Europe Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 129 Europe Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 130 Europe Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 131 Europe Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 132 Europe Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 133 Europe Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million); Table 134 Europe Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million); Table 135 Europe Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million); Table 136 Europe Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million); Table 137 Europe Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 138 Europe Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 139 Europe Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 140 Europe Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 141 Europe Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million); Table 142 Europe Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million); Table 143 Germany Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 144 Germany Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 145 Germany Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 146 Germany Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 147 Germany Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 148 Germany Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million); Table 149 Germany Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
List Of Figures: Figure 1 Global Pharmacogenetic Testing Market: Segmentation; Figure 2 Global Pharmacogenetic Testing Market: Data Triangulation; Figure 3 Global Pharmacogenetic Testing Market: Droc Analysis; Figure 4 Global Pharmacogenetic Testing Market: Global Vs Regional Market Analysis; Figure 5 Global Pharmacogenetic Testing Market: Company Research Analysis; Figure 6 Global Pharmacogenetic Testing Market: Interview Demographics; Figure 7 Global Pharmacogenetic Testing Market: Dbmr Market Position Grid; Figure 8 Global Pharmacogenetic Testing Market: Market End User Coverage Grid; Figure 9 Global Pharmacogenetic Testing Market: Segmentation; Figure 10 Increasing Adoption Of Personalized Medicine Is Driving The Growth Of The Global Pharmacogenetic Testing Market In The Forecast Period Of 2023 To 2030; Figure 11 Whole Genome Sequencing Segment Is Expected To Account For The Largest Share Of The Global Pharmacogenetic Testing Market In 2023 & 2030; Figure 12 Drivers, Restraints, Opportunities, And Challenges Of Global Pharmacogenetic Testing Market; Figure 13 Global Pharmacogenetic Testing Market: By Type, 2022; Figure 14 Global Pharmacogenetic Testing Market: By Type, 2023-2030 (Usd Million); Figure 15 Global Pharmacogenetic Testing Market: By Type, Cagr (2023-2030); Figure 16 Global Pharmacogenetic Testing Market: By Type, Lifeline Curve; Figure 17 Global Pharmacogenetic Testing Market: By Gene Type, 2022; Figure 18 Global Pharmacogenetic Testing Market: By Gene Type, 2023-2030 (Usd Million); Figure 19 Global Pharmacogenetic Testing Market: By Gene Type, Cagr (2023-2030); Figure 20 Global Pharmacogenetic Testing Market: By Gene Type, Lifeline Curve; Figure 21 Global Pharmacogenetic Testing Market: By Drug Type, 2022; Figure 22 Global Pharmacogenetic Testing Market: By Drug Type, 2023-2030 (Usd Million); Figure 23 Global Pharmacogenetic Testing Market: By Drug Type, Cagr (2023-2030); Figure 24 Global Pharmacogenetic Testing Market: By Drug Type, Lifeline Curve; Figure 25 Global Pharmacogenetic Testing Market: By Sample, 2022; Figure 26 Global Pharmacogenetic Testing Market: By Sample, 2023-2030 (Usd Million); Figure 27 Global Pharmacogenetic Testing Market: By Sample, Cagr (2023-2030); Figure 28 Global Pharmacogenetic Testing Market: By Sample, Lifeline Curve; Figure 29 Global Pharmacogenetic Testing Market: By Therapeutic Area, 2022; Figure 30 Global Pharmacogenetic Testing Market: By Therapeutic Area, 2023-2030 (Usd Million); Figure 31 Global Pharmacogenetic Testing Market: By Therapeutic Area, Cagr (2023-2030); Figure 32 Global Pharmacogenetic Testing Market: By Therapeutic Area, Lifeline Curve; Figure 33 Global Pharmacogenetic Testing Market: By Application, 2022; Figure 34 Global Pharmacogenetic Testing Market: By Application, 2023-2030 (Usd Million); Figure 35 Global Pharmacogenetic Testing Market: By Application, Cagr (2023-2030); Figure 36 Global Pharmacogenetic Testing Market: By Application, Lifeline Curve; Figure 37 Global Pharmacogenetic Testing Market: By End User, 2022; Figure 38 Global Pharmacogenetic Testing Market: By End User, 2023-2030 (Usd Million); Figure 39 Global Pharmacogenetic Testing Market: By End User, Cagr (2023-2030); Figure 40 Global Pharmacogenetic Testing Market: By End User, Lifeline Curve; Figure 41 Global Pharmacogenetic Testing Market: By Distribution Channel, 2022; Figure 42 Global Pharmacogenetic Testing Market: By Distribution Channel, 2023-2030 (Usd Million); Figure 43 Global Pharmacogenetic Testing Market: By Distribution Channel, Cagr (2023-2030); Figure 44 Global Pharmacogenetic Testing Market: By Distribution Channel, Lifeline Curve; Figure 45 Global Pharmacogenetic Testing Market: Snapshot (2022); Figure 46 Global Pharmacogenetic Testing Market: Company Share 2022 (%); Figure 47 North America Pharmacogenetic Testing Market: Company Share 2022 (%); Figure 48 Europe Pharmacogenetic Testing Market: Company Share 2022 (%); Figure 49 Aisa-pacific Pharmacogenetic Testing Market: Company Share 2022 (%)